Skip to main content
NIH funding notice RFA-AI-19-063

Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed)

Closed on December 4, 2019.

Posted
September 11, 2019
Close date
December 4, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,860,749 in first-year total cost, median $959,550.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 JBS-A (M1)]3

Most frequent institutions

  1. OAK CREST INSTITUTE OF SCIENCE1
  2. OREGON HEALTH & SCIENCE UNIVERSITY1
  3. RESEARCH TRIANGLE INSTITUTE1
Competing awards under RFA-AI-19-063 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention1R01AI154549-01JOHNSON, LEAHRESEARCH TRIANGLE INSTITUTE, NC$986,995ZAI1
2020A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission1R01AI154559-01SACHA, JONAH B.OREGON HEALTH & SCIENCE UNIVERSITY, OR$959,550ZAI1
2020A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection1R01AI154561-01MOSS, JOHN AOAK CREST INSTITUTE OF SCIENCE, CA$914,204ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.